Switching on the production of fetal hemoglobin in patients with sickle cell disease can be achieved by using CRISPR, Australian researchers believe.
Researchers are combining immunotherapies and attacking tumor defenses in efforts to improve checkpoint inhibitors.
Switching on the LZK gene in mice with spinal cord injuries led to a smaller scar, which might improve healing.
Researchers at Washington University School of Medicine have found that targeting the APOE protein helps clear Alzheimer's plaques in mice.
The past week saw the discovery of a genetic mutation that disrupts nerve signaling in ALS and the development of a noninvasive bladder cancer test.
Columbia University researchers have discovered a new link between the enzyme DPP4 and obesity—insight that could inspire new treatments for Type 2 diabetes.
Genentech scientists used an antibody to kill E. coli bacteria by blocking the enzyme BamA.
Tau secretion was thought to be a byproduct of cell death, but new research shows it is an active process.
Scientists at Dana-Farber Cancer Institute and Harvard have invented an immunotherapy “gel” that’s placed at the surgery site and is showing promising results…
UCSD researchers have developed a small molecule that weakens the virulent H3N2 strain of flu by exploiting a flaw in the mechanism the virus uses to replicate.